Akorn, Inc. Announces the Appointment of Dr. Adrienne Graves, Ph.D. to its Board of Directors

LAKE FOREST, Ill.--(BUSINESS WIRE)--Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, announced today that its Board of Directors appointed Dr. Adrienne Graves, Ph.D., as Director of the Company, effective March 2, 2012.